CDX2 and colorectal cancer: More recently, Neumann et al. 24 found, in a cohort of 503 patients with colorectal cancer (FIRE‐3) and in a case–control collection of 50 right‐sided tumours with and without synchronous distant metastasis, that CDX2 was not an independent prognostic biomarker in colorectal cancer.